Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
2,539
Funds Holding Change
+50
Funds Holding Growth
+2%
Value
$872B
Holding in Top 10
1,103
Top 10 Change
+52
Top 10 Growth
+5%
Value Growth
+5%
New
125
Increased
1,137
Reduced
1,167
Closed
48
Capital Inflow
$35.2B
Capital Outflow
$27.7B
Net Capital Flow
+$7.49B
Capital Flow Change
+$8.84B
Calls
$9.14B
Puts
$8.75B
Net Calls
+$390M
Put/Call Ratio
0.96